The Presentation will be based on Mentanine®, an Omega3 + CBD Master Formulation, that addresses Mental Health Ailments. The presentation will include a description of how the formula works synergistically with significantly increased efficacy while reducing dosage, capable of acting on mental health issues inside the Central Nervous System (CNS) by crossing the Blood Brain Barrier (BBB). Pre-clinical trials also demonstrated that Mentanine® reduces and eliminates the negative side effects associated with high consumption of CBD. As well, the importance of sublingual delivery and bypassing the digestive system and liver will be discussed.
About Paul Ramsay
Over 30 years of business development and management experience, was the Co-founder and former CEO and VP Business Development of Cymat Corp, (TSX: CYM) with a market valuation over $150 million upon his resignation in 2002, was instrumental in securing the Stabilized Aluminum Foam (SAF) license from Alcan International Ltd., successfully negotiated a $10 Million technology development program with Industry Canada (TPC),.participated in the completion of $25 million in financing with financial institutions. Mr. Ramsay also introduced and sold several newly developed products to major corporations.